| Examination of Ocular Surface Effects With Administration of Travatan Z and XALATAN (NCT00798759) | Alcon Research | 2008-12-01 |
| A Dose-Volume Study of a Treatment for Elevated IOP Due to Open-Angle Glaucoma or Ocular Hypertension (NCT00788541) | Alcon Research | 2008-12-01 |
| An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects (NCT00811564) | Allergan | 2008-12-01 |
| Safety and Efficacy of a Glaucoma Drug Delivery System (NCT00824720) | Vistakon Pharmaceuticals | 2008-12-01 |
| Patient Satisfaction With Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT00804648) | Vistakon Pharmaceuticals | 2008-11-01 |
| 1 Year Study Trav/Brinz QD Fixed Combination Versus COSOPT (NCT00767481) | Alcon Research | 2008-10-01 |
| Travoprost/Brinzolamide Fixed Combination Versus Travatan and Versus AZOPT (NCT00767494) | Alcon Research | 2008-10-01 |
| Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health (NCT00761319) | Alcon Research | 2008-10-01 |
| Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma (NCT00753168) | Othera Pharmaceuticals | 2008-09-01 |
| IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids (NCT00744666) | Hotel Dieu Hospital | 2008-09-01 |
| Phase IV Randomised Double-masked Clinical Trial: Assessing Morning Versus Evening Dosing of a Fixed Dose Combination of Travoprost 0.004% / Timolol Maleate 0.5% in Patients With Primary Open-angle Glaucoma or Ocular Hypertension (NCT00759239) | Alcon Research | 2008-09-01 |
| Effects of Travatan Z and Xalatan on Ocular Surface Health (NCT00708422) | Alcon Research | 2008-07-01 |
| Travatan Z in Ocular Surface Health in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00690794) | Alcon Research | 2008-07-01 |
| Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects (NCT00735449) | Allergan | 2008-07-01 |
| Comparison of Istalol™ 0.5% QD (Timolol Maleate/Sorbitol Complex, ISTA Pharmaceutical) to Brimonidine Tartrate 0.1% BID as Adjunctive Therapy to Latanoprost 0.005% in Adults With Ocular Hypertension (OHT) or Open-Angle Glaucoma (OAG) (NCT00698945) | Bp Consulting, Inc | 2008-06-01 |
| Safety and Efficacy of Travoprost/Timolol BAC-free (NCT00760539) | Alcon Research | 2008-06-01 |
| A Phase III Study of Travoprost/Timolol Combination in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00672997) | Alcon Research | 2008-05-01 |
| Glaucoma Adherence Study, Spain (NCT00680329) | Alcon Research | 2008-05-01 |
| A Phase 1, Open-Label Study of Latanoprost Acid Plasma Concentrations in Pediatric and Adult Glaucoma Patients Treated With Latanoprost. (NCT00638742) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2008-05-01 |
| Glaucoma Adherence Study (NCT00676637) | Alcon Research | 2008-05-01 |
| Dry Eye and Irritation Comparison of Latanoprost With the Preservative Versus Travoprost Without Preservative (NCT00803387) | United States Air Force | 2008-04-01 |
| Travoprost New Formulations in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00670033) | Alcon Research | 2008-04-01 |
| Safety and Efficacy of Punctum Plug Delivery System in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT00650702) | Mati Therapeutics Inc. | 2008-03-01 |
| Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular Hypertension (NCT00650338) | Santen Inc. | 2008-03-01 |
| Evaluation of Pascal Laser Trabeculoplaty (NCT00838721) | Santa Clara Valley Health & Hospital System | 2008-03-01 |
| Ocular Signs and Symptoms in Glaucoma Patients Switched From Latanoprost 0.005% to Preservative Free Tafluprost Eye Drops (NCT00596791) | Santen Oy | 2008-01-01 |
| Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. (NCT00572455) | Pfizer | 2007-12-11 |
| Patient Preference Study (NCT00576342) | Alcon Research | 2007-12-01 |
| Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension (NCT00541242) | Allergan | 2007-12-01 |
| A Phase 2, Dose Finding Study of PF-03187207 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension. (NCT00595101) | Bausch & Lomb Incorporated | 2007-12-01 |
| Distribution of Risk Factors in Ocular Hypertension and Open-Angle Glaucoma Patients in Canada (NCT00334750) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-11-01 |
| A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension (NCT00538304) | Allergan | 2007-11-01 |
| Adjunctive Study of AL-37807 Ophthalmic Suspension (NCT00620256) | Alcon Research | 2007-11-01 |
| Safety, Efficacy, and Pharmacokinetic Profile of DNB-001 in Subjects With Elevated Intraocular Pressure (NCT00683501) | Danube Pharmaceuticals, Inc. | 2007-10-01 |
| Adherence Assessment With Travalert Dosing Aid (NCT00508469) | Alcon Research | 2007-10-01 |
| Safety and Intraocular Pressure (IOP) Lowering Efficacy of Low Dose Travoprost (NCT00637130) | Alcon Research | 2007-10-01 |
| Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues (NCT00539526) | Allergan | 2007-09-01 |
| IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00527501) | Alcon Research | 2007-08-01 |
| Tolerability, Safety and Efficacy of RKI983 Eye Drops in Subjects With Primary Open Angle Glaucoma and Ocular Hypertension (NCT00515424) | Novartis | 2007-07-01 |
| Non Interventional Study in Patients With Open Angle Glaucoma and/or Ocular Hypertension Treated With XALATAN® (NCT00486252) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2007-06-01 |
| Dry Eye Study With Cosopt® Over 8 Weeks in Patients With Open-Angle Glaucoma or Ocular Hypertension (0507A-152)(COMPLETED) (NCT00545064) | Merck Sharp & Dohme LLC | 2007-05-23 |
| A Single Dose Comfort Comparison of Travatan Z in One Eye Versus Xalatan in the Opposite Eye in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension (NCT00527592) | Alcon Research | 2007-05-01 |
| Tolerability, Safety and Efficacy of SAD448 in Subjects With Ocular Hypertension (NCT00503360) | Novartis | 2007-04-01 |
| An Open-Label Study of an Ophthalmic Solution to Reduce Intraocular Pressure in Patients With Ocular Hypertension (NCT00825396) | Chakshu Research, Inc. | 2007-04-01 |
| A Investigator Masked Parallel Comparison of Tolerability of Combigan and Cosopt (NCT00621335) | DBYAN Medicine Professional Corporation | 2007-03-01 |
| A Phase IV Study of Travoprost + Brinzolamide to Treat Glaucoma or Ocular Hypertension (NCT00471380) | Alcon Research | 2007-03-01 |
| Dose-Finding Study Comparing the Safety and Efficacy of Latanoprost to a Novel Treatment for Glaucoma (NCT00441883) | Bausch & Lomb Incorporated | 2007-03-01 |
| Dose Response Study of AL-37807 Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension (NCT00465621) | Alcon Research | 2007-03-01 |
| Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension (NCT00471068) | Alcon Research | 2007-03-01 |
| Study of INS115644 Ophthalmic Solution in Subjects With Ocular Hypertension or Glaucoma (NCT00443924) | Merck Sharp & Dohme LLC | 2007-03-01 |
| A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension (NCT00465803) | Alcon Research | 2007-03-01 |
| Neurovascular Coupling in Eyes of Glaucoma Patients (NCT00429819) | University Hospital, Basel, Switzerland | 2006-12-01 |
| Neurovascular Coupling in Eyes of Glaucoma Patients (NCT00430209) | University Hospital, Basel, Switzerland | 2006-12-01 |
| 24-hour IOP-lowering Effect of Brimonidine 0.1% (NCT00457795) | Allergan | 2006-12-01 |
| Study to Determine if Taking OTC Non-Steroidal Anti-Inflammatory Affects Eye Pressure in Patients Using Glaucoma Drops (NCT00402493) | Philadelphia Eye Associates | 2006-12-01 |
| A Study Comparing Xalacom And Xalatan In Patients With Primary Open Angle Glaucoma (POAG) Or Ocular Hypertension (OH). (NCT00383019) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2006-11-14 |
| Effect of Epigallocatechin-Gallate on Inner Retinal Function in Ocular Hypertension and Early Glaucoma (NCT00476138) | Catholic University of the Sacred Heart | 2006-11-01 |
| Study of the Intraocular Pressure (IOP)-Lowering Efficacy of Azopt 1.0% Compared to Timolol 0.5% in Patients With Glaucoma or Ocular Hypertension (NCT00300079) | Alcon Research | 2006-09-01 |
| Randomized Prospective Study of Selective Laser Trabeculoplasty (SLT) Versus Argon Trabeculoplasty (ALT) in Patients With Pseudoexfoliation Glaucoma and Ocular Hypertension (NCT01126203) | University of Calgary | 2006-09-01 |
| Utility of Heidelberg Retina Tomograph in Monitoring Glaucoma Progression (NCT00424996) | University Health Network, Toronto | 2006-08-01 |
| Comparison of the Alpha-2 Agonists for Prevention of Intraocular Pressure Elevation After Selective Laser Trabeculoplasty (NCT00567411) | Walter Reed Army Medical Center | 2006-08-01 |
| Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005% (NCT00440141) | Allergan | 2006-07-01 |
| A Study to Evaluate the Effectiveness of Cosopt® as First Line Therapy (MK-0507A-153) (NCT00546286) | Merck Sharp & Dohme LLC | 2006-05-31 |
| A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00326092) | Alcon Research | 2006-05-01 |
| The Efficacy of Selective Laser Trabeculoplasty (NCT00347893) | Glaucoma Research & Education Group | 2006-05-01 |
| A Phase II Study of AL-37807 to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00372931) | Alcon Research | 2006-05-01 |
| 24-Hour Intraocular Pressure (IOP) And Blood Pressure Control In Glaucoma And Ocular Hypertension Patients (NCT00330577) | Aristotle University Of Thessaloniki | 2006-04-01 |
| A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00333125) | Alcon Research | 2006-04-01 |
| Intraocular Pressure With Loteprednol and Dexamethasone (NCT00781300) | Federal University of São Paulo | 2006-03-01 |
| Clinical Study of A Fixed Combination of Timolol-Brimonidine-Dorzolamide (NCT01062971) | Laboratorios Sophia S.A de C.V. | 2006-02-01 |
| A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00293761) | Alcon Research | 2006-01-01 |
| Comparison of Brimonidine Purite, Dorzolamide, and Brinzolamide as Adjunctive Therapy to Prostaglandin Analogs (NCT00675207) | Northwestern Ophthalmic Institute S.C. | 2006-01-01 |
| Relationship Between Central Corneal Thickness and Intraocular Pressure Measures Instruments. (NCT00347191) | Aston University | 2006-01-01 |
| A Long-term Safety Study of Once-daily Travatan (NCT00051168) | Alcon Research | 2006-01-01 |
| A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma (NCT00277498) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-12-01 |
| An Evaluation of Use of Topical Ocular Hypotensive Medication by Compliance (NCT00329095) | Robin, Alan L., M.D. | 2005-12-01 |
| Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension (NCT00300443) | Allergan | 2005-12-01 |
| A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00287521) | Alcon Research | 2005-11-01 |
| A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00314158) | Alcon Research | 2005-11-01 |
| Assessing Cosopt Switch Patients (NCT00273442) | Pharmaceutical Research Network | 2005-11-01 |
| Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients (NCT00651612) | Allergan | 2005-11-01 |
| A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00314171) | Alcon Research | 2005-10-01 |
| Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure (NCT00230763) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-09-01 |
| Pharmacodynamics of Tafluprost 0.0015% Eye Drops: a Comparison Between the Preserved and Unpreserved Formulation (NCT00918346) | Santen Oy | 2005-09-01 |
| Cosopt Versus Xalacom (NCT00273481) | Pharmaceutical Research Network | 2005-09-01 |
| Efficacy and Tolerability of Xalatan in Patients (NCT00950690) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-07-01 |
| A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma (NCT00159653) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-07-01 |
| A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma (NCT00140049) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2005-07-01 |
| Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT00822055) | Allergan | 2005-05-01 |
| Latanoprost Versus Fotil (NCT00304785) | Pharmaceutical Research Network | 2005-05-01 |
| Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) (NCT00108017) | Merck Sharp & Dohme LLC | 2005-04-01 |
| Cosopt Versus Xalatan (NCT00273429) | Pharmaceutical Research Network | 2005-04-01 |
| Safety and Efficacy Study of Different Formulations of Bimatoprost Once-Daily in Patients With Glaucoma or Ocular Hypertension (NCT00652496) | Allergan | 2005-01-01 |
| Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension (NCT00168363) | Allergan | 2005-01-01 |
| Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension (NCT00822081) | Bp Consulting, Inc | 2005-01-01 |
| Phase III Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients (NCT00288951) | Alcon Research | 2004-10-01 |
| Safety and Efficacy Study of Bimatoprost, Latanoprost, and Travoprost in Patients With Elevated Intraocular Pressure (IOP) and Open-angle Glaucoma (OAG) (NCT00716742) | Allergan | 2004-09-01 |
| A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00293800) | Alcon Research | 2004-07-01 |
| A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension (NCT00293787) | Alcon Research | 2004-06-01 |
| Study of Brinzolamide and Timolol When Added to Travoprost in Primary Open-angle Glaucoma or Ocular Hypertension (NCT00372827) | Alcon Research | 2004-02-01 |